Research into biomembrane-grafted dendrimer–polymeric conjugates, which target the p53 protein in cancer cells, exemplifies how innovative nanotechnology can lead to more effective and broadly applicable cancer treatments [96]. The gene discussed is TP53; the disease is cancer.